ROYALTY PHARMA PLC
COM · CUSIP 67709Q104
1
institutional holders
+0 vs Q4 2022
24.5k
shares reported held*
$888.4kreported value*
0 new
1 added
0 reduced
0 sold out
net bought ≈ $286.5k (+7.9k shares)
* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable. Implied quarter-end price ≈ $36.26.
Trends to Q1 2023
Institutional holders
Managers reporting a position, each quarter
Numbers
| Quarter | Holders |
|---|---|
| Q4 2022 | 1 |
| Q1 2023 | 1 |
Biggest buyers
| Aubrey Capital Management Ltd | Added | +7.9k |
Biggest sellers
| None |
Holders, Q1 2023
| Manager | Shares | Change |
|---|---|---|
| Aubrey Capital Management Ltd 0.52% of their portfolio | 24.5k $888.4k | Added +7.9k |